MANILA, Philippines — The Food and Drug Administration (FDA) is seeking the approval of measures that will allow it to have more “flexibility” in its regulations in times of emergencies.
FDA Director General Eric Domingo made the remark Thursday during a House hearing of the committee on good government and public accountability on the guidelines of the FDA and the Department Health (DOH) for COVID-19 drug registration, distribution, and sale sought.
Some lawmakers said some of the guidelines have become “detrimental” in the fight against the pandemic.
“‘Yun nga po ang hinihiling namin kasi ang batas ng FDA para talagang walang emergency lagi kaya ang hinihiling namin sa l…
Keep on reading: FDA chief seeks law to provide flexibility to regulations during emergencies